Sign up to save your podcasts
Or
Share S2 E8: Novo Nordisk Breakthrough Weigh-Lost Drug, Q3 Market Performance & African Startups Collapse
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S2 E8: Novo Nordisk Breakthrough Weigh-Lost Drug, Q3 Market Performance & African Startups Collapse
In Episode 8 of season 2, Novo Nordisk Breakthrough WeightLoss Drug, Q3 Market Performance etc w/James Okpare & Sam Adekunle
In this episode, the podcast centers on Wegovy, a breakthrough weight loss drug from Novo Nordisk tackling obesity. In addition, it reviews the US Federal Reserve's report on the Q3 stock market performance. Lastly, Sam and James dive into the recent collapse of African startups influenced by financial management, regulatory challenges, and funding constraints.
View all episodes
By Business BubbleIn Episode 8 of season 2, Novo Nordisk Breakthrough WeightLoss Drug, Q3 Market Performance etc w/James Okpare & Sam Adekunle
In this episode, the podcast centers on Wegovy, a breakthrough weight loss drug from Novo Nordisk tackling obesity. In addition, it reviews the US Federal Reserve's report on the Q3 stock market performance. Lastly, Sam and James dive into the recent collapse of African startups influenced by financial management, regulatory challenges, and funding constraints.